Cognex (CGNX) Financials

$62.26 +3.43 (+5.83%)

Closing price 04:00 PM Eastern

Extended Trading

$71.06 +8.80 (+14.13%)

As of 08:00 PM Eastern

Annual Income Statements for Cognex

This table shows Cognex's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	187	144	177	219	204	176	280	216	113	106	114
Consolidated Net Income / (Loss)	187	144	177	219	204	176	280	216	113	106	114
Net Income / (Loss) Continuing Operations	108	144	177	219	204	176	280	216	113	106	114
Total Pre-Tax Income	127	162	266	235	163	187	319	251	135	131	183
Total Operating Income	122	154	259	221	143	171	315	246	131	115	163
Total Gross Profit	348	398	579	600	536	605	760	722	601	626	665
Total Revenue	451	530	766	806	726	811	1,037	1,006	838	915	994
Operating Revenue	451	530	766	806	726	811	1,037	1,006	838	915	994
Total Cost of Revenue	103	131	187	206	190	206	277	284	236	289	329
Operating Cost of Revenue	103	131	187	206	190	206	277	284	236	289	329
Total Operating Expenses	226	244	320	379	393	434	445	476	471	511	503
Selling, General & Admin Expense	157	166	221	263	274	268	309	312	339	371	364
Research & Development Expense	70	78	99	116	119	131	135	141	139	140	139
Other Operating Expenses / (Income)	-	-	-	-	-	-	0.00	21	-8.00	0.00	0.00
Total Other Income / (Expense), net	5.44	8.01	7.60	13	20	16	3.80	4.47	4.65	16	20
Interest & Investment Income	3.67	7.04	9.54	15	20	13	6.66	6.72	14	14	17
Other Income / (Expense), net	1.77	0.97	-1.94	-1.28	0.70	3.39	-2.86	-2.25	-9.45	2.45	3.29
Income Tax Expense	19	18	90	15	-41	11	39	35	22	25	68
Basic Earnings per Share	$1.08	$0.84	$1.02	$1.27	$1.19	$1.02	$1.59	$1.24	$0.66	$0.62	$0.68
Weighted Average Basic Shares Outstanding	172.59M	170.68M	173.29M	172.33M	171.19M	173.49M	176.46M	173.41M	172.25M	171.44M	168.05M
Diluted Earnings per Share	$1.06	$0.83	$0.98	$1.24	$1.16	$1.00	$1.56	$1.23	$0.65	$0.62	$0.68
Weighted Average Diluted Shares Outstanding	175.98M	174.14M	179.55M	177.41M	175.27M	176.59M	179.92M	174.87M	173.40M	172.61M	169.37M
Weighted Average Basic & Diluted Shares Outstanding	86.20M	170M	173.20M	172.70M	172.61M	352.06M	347.83M	345.07M	343.27M	169.87M	165.71M
Cash Dividends to Common per Share	$0.11	$0.15	$0.17	$0.19	$0.21	$2.23	$0.25	$0.27	$0.29	$0.31	$0.33

This table shows Cognex's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	7/2/2023	10/1/2023	12/31/2023	3/31/2024	6/30/2024	9/29/2024	12/31/2024	3/30/2025	6/29/2025	9/28/2025	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	57	19	11	12	36	30	28	24	41	18	33
Consolidated Net Income / (Loss)	57	19	11	12	36	30	28	24	41	18	33
Net Income / (Loss) Continuing Operations	57	19	11	12	36	30	28	24	41	18	33
Total Pre-Tax Income	68	27	14	18	42	37	36	28	48	63	44
Total Operating Income	65	31	13	14	38	32	31	26	43	58	35
Total Gross Profit	180	143	135	142	167	159	158	144	168	187	166
Total Revenue	243	197	197	211	239	235	230	216	249	277	252
Operating Revenue	243	197	197	211	239	235	230	216	249	277	252
Total Cost of Revenue	63	54	62	69	73	75	72	72	81	90	86
Operating Cost of Revenue	63	54	62	69	73	75	72	72	81	90	86
Total Operating Expenses	115	112	122	128	128	128	127	118	124	130	131
Selling, General & Admin Expense	83	82	90	91	93	93	94	84	91	94	95
Research & Development Expense	34	33	35	37	35	35	33	35	33	35	36
Total Other Income / (Expense), net	2.60	-3.64	1.63	3.36	3.11	4.99	4.96	1.71	4.63	5.10	8.80
Interest & Investment Income	4.10	4.89	1.52	3.12	3.12	3.56	4.17	3.99	4.04	4.20	4.72
Other Income / (Expense), net	-1.49	-8.53	0.11	0.24	-0.01	1.43	0.79	-2.28	0.59	0.90	4.08
Income Tax Expense	10	8.09	3.13	5.54	5.36	6.96	7.45	4.20	7.55	45	11
Basic Earnings per Share	$0.33	$0.11	$0.07	$0.07	$0.21	$0.17	$0.17	$0.14	$0.24	$0.11	$0.19
Weighted Average Basic Shares Outstanding	172.43M	172.17M	172.25M	171.69M	171.57M	171.52M	171.44M	169.27M	167.89M	167.84M	168.05M
Diluted Earnings per Share	$0.33	$0.11	$0.06	$0.07	$0.21	$0.17	$0.17	$0.14	$0.24	$0.10	$0.20
Weighted Average Diluted Shares Outstanding	173.62M	173.35M	173.40M	172.59M	172.73M	172.75M	172.61M	170.39M	168.56M	169.32M	169.37M
Weighted Average Basic & Diluted Shares Outstanding	172.29M	172.14M	343.27M	171.66M	171.50M	171.52M	169.87M	167.86M	167.90M	167.60M	165.71M
Cash Dividends to Common per Share	$0.07	$0.07	$0.08	$0.08	$0.08	$0.08	$0.08	$0.08	$0.08	$0.08	$0.08

This table details how cash moves in and out of Cognex's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-3.72	28	27	2.72	63	98	-83	-4.79	21	-17	77
Net Cash From Operating Activities	128	182	224	223	253	242	314	243	113	149	246
Net Cash From Continuing Operating Activities	128	182	224	223	253	242	314	243	113	149	246
Net Income / (Loss) Continuing Operations	187	144	177	219	204	176	280	216	113	106	114
Consolidated Net Income / (Loss)	187	144	177	219	204	176	280	216	113	106	114
Depreciation Expense	9.87	12	14	18	22	22	17	16	17	21	20
Amortization Expense	4.94	3.77	3.51	3.18	2.76	5.64	8.55	8.24	6.36	12	9.77
Non-Cash Adjustments To Reconcile Net Income	-58	19	32	43	57	72	48	106	63	56	45
Changes in Operating Assets and Liabilities, net	-15	3.63	-1.17	-60	-32	-34	-39	-103	-87	-46	56
Net Cash From Investing Activities	-11	-122	-106	-11	-157	169	-253	-4.45	32	-39	28
Net Cash From Continuing Investing Activities	-11	-122	-106	-11	-157	169	-253	-4.45	32	-39	28
Purchase of Property, Plant & Equipment	-18	-13	-29	-37	-22	-13	-15	-20	-23	-15	-8.74
Acquisitions	-11	-14	-24	-4.27	-167	1.00	0.00	-5.05	-257	-1.44	0.00
Purchase of Investments	-687	-752	-637	-782	-1,032	-923	-668	-234	-184	-851	-290
Sale and/or Maturity of Investments	601	657	584	813	1,063	1,105	431	254	496	828	320
Other Investing Activities, net	104	-0.11	-0.29	-	-	-	-	-	0.00	0.00	6.70
Net Cash From Financing Activities	-117	-29	-100	-210	-32	-317	-142	-240	-126	-118	-207
Net Cash From Continuing Financing Activities	-117	-29	-100	-210	-32	-317	-142	-240	-126	-118	-207
Repurchase of Common Equity	-126	-47	-124	-204	-62	-51	-162	-204	-80	-67	-152
Payment of Dividends	-18	-25	-29	-32	-35	-391	-43	-46	-49	-52	-55
Issuance of Common Equity	28	43	55	27	65	126	63	9.86	3.27	0.99	-0.45
Effect of Exchange Rate Changes	-4.67	-3.35	8.29	-	-0.52	2.67	-2.82	-3.37	1.70	-8.25	9.99

This table details how cash moves in and out of Cognex's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	7/2/2023	10/1/2023	12/31/2023	3/31/2024	6/30/2024	9/29/2024	12/31/2024	3/30/2025	6/29/2025	9/28/2025	12/31/2025
Net Change in Cash & Equivalents	13	218	-193	-64	38	20	-11	-42	36	67	17
Net Cash From Operating Activities	30	41	14	14	28	56	51	41	43	87	75
Net Cash From Continuing Operating Activities	30	41	14	14	28	56	51	41	43	87	75
Net Income / (Loss) Continuing Operations	57	19	11	12	36	30	28	24	41	18	33
Consolidated Net Income / (Loss)	57	19	11	12	36	30	28	24	41	18	33
Depreciation Expense	4.19	4.38	4.71	5.28	5.19	5.43	5.37	5.31	5.32	4.89	4.77
Amortization Expense	1.24	0.89	2.58	3.12	2.98	3.26	2.36	2.47	2.53	2.51	2.27
Non-Cash Adjustments To Reconcile Net Income	13	14	19	15	15	13	6.49	10	13	-0.53	22
Changes in Operating Assets and Liabilities, net	-46	2.94	-23	-21	-31	4.49	8.84	-1.29	-19	63	13
Net Cash From Investing Activities	17	200	-179	-49	35	-27	2.23	33	-3.97	19	-20
Net Cash From Continuing Investing Activities	17	200	-179	-49	35	-27	2.23	33	-3.97	19	-20
Purchase of Property, Plant & Equipment	-4.70	-5.86	-7.02	-4.06	-4.51	-4.40	-2.07	-2.50	-2.19	-1.45	-2.60
Purchase of Investments	-48	-80	-9.73	-234	-36	-379	-202	-113	-101	-35	-41
Sale and/or Maturity of Investments	70	286	94	190	76	356	206	149	100	55	17
Net Cash From Financing Activities	-31	-22	-33	-25	-22	-15	-56	-118	-13	-38	-37
Net Cash From Continuing Financing Activities	-31	-22	-33	-25	-22	-15	-56	-118	-13	-38	-37
Repurchase of Common Equity	-25	-10	-20	-9.34	-11	-3.96	-43	-102	-	-24	-25
Payment of Dividends	-12	-12	-13	-13	-13	-13	-14	-14	-13	-13	-14
Issuance of Common Equity	5.71	0.62	-0.01	-2.86	0.99	1.67	1.20	-2.59	0.18	0.26	1.71
Effect of Exchange Rate Changes	-2.47	-1.38	5.19	-3.33	-2.82	6.75	-8.86	2.43	10	-1.83	-0.77

This table presents Cognex's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	888	1,039	1,288	1,290	1,886	1,801	2,004	1,958	2,018	1,993	2,017
Total Current Assets	444	526	630	780	607	602	640	718	679	613	697
Cash & Equivalents	52	80	107	108	171	269	186	181	203	186	263
Short-Term Investments	296	341	298	427	240	103	137	219	129	60	74
Accounts Receivable	43	58	127	127	108	131	134	128	117	146	164
Inventories, net	37	27	68	83	60	61	113	122	162	158	138
Prepaid Expenses	16	21	31	34	27	37	69	67	68	63	59
Plant, Property, & Equipment, net	53	54	78	91	89	79	78	80	106	98	86
Total Noncurrent Assets	390	458	580	418	1,189	1,120	1,286	1,161	1,233	1,281	1,233
Long-Term Investments	273	324	423	262	433	395	584	454	244	341	305
Goodwill	81	95	113	113	243	244	242	243	393	385	386
Intangible Assets	6.32	8.31	13	10	39	16	12	12	113	91	81
Noncurrent Deferred & Refundable Income Taxes	27	28	27	29	450	435	419	407	400	392	383
Other Noncurrent Operating Assets	2.61	2.32	2.49	3.93	23	30	30	44	82	72	77
Total Liabilities & Shareholders' Equity	888	1,039	1,288	1,290	1,886	1,801	2,004	1,958	2,018	1,993	2,017
Total Liabilities	62	76	192	154	530	539	574	520	513	475	525
Total Current Liabilities	54	66	113	91	120	132	189	188	152	169	184
Accounts Payable	7.86	9.83	23	16	18	16	44	27	21	38	50
Accrued Expenses	33	43	68	60	52	77	92	93	72	72	91
Current Deferred Revenue	12	8.21	9.42	9.85	14	21	36	41	32	25	21
Current Deferred & Payable Income Tax Liabilities	0.99	5.19	12	5.06	30	9.38	8.58	18	17	26	9.14
Other Current Liabilities	-	-	-	0.00	5.65	8.11	7.79	8.45	9.62	8.85	12
Total Noncurrent Liabilities	8.40	10	79	63	410	406	385	332	361	306	341
Noncurrent Deferred & Payable Income Tax Liabilities	5.15	5.36	6.80	8.07	344	329	309	266	274	244	275
Other Noncurrent Operating Liabilities	3.25	4.87	5.90	3.87	15	28	33	33	69	62	66
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	826	963	1,096	1,135	1,356	1,262	1,430	1,438	1,505	1,518	1,492
Total Preferred & Common Equity	826	963	1,096	1,135	1,356	1,262	1,430	1,438	1,505	1,518	1,492
Preferred Stock	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	826	963	1,096	1,135	1,356	1,262	1,430	1,438	1,505	1,518	1,492
Common Stock	311	375	462	530	640	808	915	980	1,038	1,091	1,139
Retained Earnings	567	644	669	646	753	488	563	528	513	499	406
Accumulated Other Comprehensive Income / (Loss)	-52	-56	-35	-41	-37	-34	-48	-69	-45	-73	-53

This table presents Cognex's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	10/2/2022	4/2/2023	7/2/2023	10/1/2023	3/31/2024	6/30/2024	9/29/2024	3/30/2025	6/29/2025	9/28/2025
Total Assets	1,900	1,974	1,998	1,990	2,013	2,004	2,063	1,933	2,004	2,003
Total Current Assets	787	722	718	847	662	681	672	578	626	671
Cash & Equivalents	266	164	177	396	139	177	197	144	179	246
Short-Term Investments	208	217	191	117	139	112	91	57	49	54
Accounts Receivable	98	147	150	132	141	161	160	164	186	172
Inventories, net	109	127	126	134	171	157	155	152	145	144
Prepaid Expenses	106	68	73	68	71	74	69	61	67	55
Plant, Property, & Equipment, net	79	81	82	83	104	103	103	96	93	90
Total Noncurrent Assets	1,033	1,171	1,198	1,060	1,248	1,220	1,288	1,259	1,284	1,242
Long-Term Investments	343	463	463	333	278	266	319	312	324	300
Goodwill	238	242	242	241	386	381	392	390	397	392
Intangible Assets	9.42	11	11	9.99	105	99	103	91	92	87
Noncurrent Deferred & Refundable Income Taxes	405	410	407	403	398	397	395	390	387	384
Other Noncurrent Operating Assets	38	44	75	73	80	78	79	75	83	79
Total Liabilities & Shareholders' Equity	1,900	1,974	1,998	1,990	2,013	2,004	2,063	1,933	2,004	2,003
Total Liabilities	511	528	518	501	524	497	496	487	497	513
Total Current Liabilities	161	214	180	170	188	169	171	184	190	169
Accounts Payable	22	27	26	23	27	23	30	43	42	45
Accrued Expenses	64	84	84	79	70	75	77	68	78	87
Current Deferred Revenue	55	58	43	40	40	41	30	40	53	24
Current Deferred & Payable Income Tax Liabilities	12	38	19	19	40	21	24	23	5.48	2.71
Other Current Liabilities	8.11	8.18	8.19	7.98	9.80	9.41	9.81	10	11	11
Total Noncurrent Liabilities	350	314	337	332	336	329	325	303	307	344
Noncurrent Deferred & Payable Income Tax Liabilities	272	264	257	253	268	263	257	239	235	275
Other Noncurrent Operating Liabilities	78	50	81	79	68	66	69	64	72	68
Commitments & Contingencies	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,389	1,446	1,480	1,489	1,489	1,507	1,567	1,446	1,506	1,490
Total Preferred & Common Equity	1,389	1,446	1,480	1,489	1,489	1,507	1,567	1,446	1,506	1,490
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,389	1,446	1,480	1,489	1,489	1,507	1,567	1,446	1,506	1,490
Common Stock	961	993	1,011	1,024	1,048	1,062	1,077	1,098	1,111	1,123
Retained Earnings	511	518	538	534	502	515	528	406	433	412
Accumulated Other Comprehensive Income / (Loss)	-82	-64	-69	-70	-61	-70	-38	-59	-38	-46

This table displays calculated financial ratios and metrics derived from Cognex's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	5.65%	17.52%	44.68%	5.25%	-10.01%	11.77%	27.88%	-2.99%	-16.75%	9.19%	8.73%
EBITDA Growth	-3.36%	23.46%	60.78%	-11.89%	-30.61%	20.35%	67.29%	-20.40%	-46.05%	3.89%	30.16%
EBIT Growth	-4.13%	25.75%	65.72%	-14.43%	-34.82%	21.36%	79.53%	-21.86%	-50.30%	-3.08%	41.13%
NOPAT Growth	-4.19%	32.78%	25.46%	20.41%	-13.72%	-9.88%	72.04%	-23.45%	-48.34%	-15.03%	9.54%
Net Income Growth	53.99%	-23.19%	22.98%	24.08%	-7.02%	-13.58%	58.86%	-22.99%	-47.46%	-6.24%	7.79%
EPS Growth	53.99%	-23.19%	18.07%	26.53%	-6.45%	-13.79%	56.00%	-21.15%	-47.15%	-4.62%	9.68%
Operating Cash Flow Growth	-21.68%	41.89%	23.20%	-0.39%	13.36%	-4.31%	29.56%	-22.50%	-53.61%	32.03%	64.69%
Free Cash Flow Firm Growth	-43.20%	74.66%	-1.73%	12.62%	-95.86%	3,011.83%	40.97%	-39.55%	-256.37%	138.82%	101.18%
Invested Capital Growth	18.81%	6.51%	23.12%	26.14%	51.14%	-3.06%	5.65%	11.75%	58.95%	0.18%	-8.70%
Revenue Q/Q Growth	2.01%	8.24%	6.22%	1.30%	-3.14%	7.11%	2.01%	-0.46%	-4.86%	3.75%	2.33%
EBITDA Q/Q Growth	-2.35%	8.62%	6.33%	-1.58%	-13.04%	28.43%	-2.12%	0.05%	-22.78%	14.65%	3.73%
EBIT Q/Q Growth	-2.84%	9.42%	6.50%	-2.22%	-15.50%	34.35%	-2.08%	0.24%	-26.66%	19.03%	4.89%
NOPAT Q/Q Growth	-4.10%	10.66%	-24.92%	48.87%	17.09%	-3.56%	-4.06%	-0.57%	-27.30%	18.41%	2.00%
Net Income Q/Q Growth	-4.04%	10.48%	-25.39%	50.08%	20.66%	-5.87%	-5.35%	0.83%	-28.02%	19.22%	3.92%
EPS Q/Q Growth	-4.04%	10.48%	-28.47%	45.88%	17.17%	-7.41%	-6.02%	1.65%	-28.57%	21.57%	4.62%
Operating Cash Flow Q/Q Growth	-30.58%	20.59%	4.11%	-5.30%	-1.56%	6.69%	-8.12%	4.75%	-31.43%	32.91%	10.58%
Free Cash Flow Firm Q/Q Growth	-42.98%	17.33%	15.93%	-15.15%	-96.70%	3,440.33%	-9.09%	0.93%	-397.31%	138.26%	7.27%
Invested Capital Q/Q Growth	-7.27%	-8.83%	-26.14%	-0.72%	59.09%	0.41%	2.99%	2.20%	44.41%	-3.09%	-4.46%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	77.23%	75.25%	75.55%	74.45%	73.85%	74.55%	73.26%	71.75%	71.79%	68.43%	66.92%
EBITDA Margin	30.65%	32.20%	35.78%	29.95%	23.10%	24.87%	32.53%	26.69%	17.30%	16.46%	19.70%
Operating Margin	26.97%	29.10%	33.79%	27.43%	19.65%	21.03%	30.38%	24.47%	15.61%	12.58%	16.35%
EBIT Margin	27.36%	29.28%	33.54%	27.27%	19.75%	21.44%	30.11%	24.25%	14.48%	12.85%	16.68%
Profit (Net Income) Margin	41.52%	27.14%	23.07%	27.19%	28.10%	21.72%	26.99%	21.42%	13.52%	11.61%	11.51%
Tax Burden Percent	147.35%	88.66%	66.32%	93.47%	125.08%	94.26%	87.76%	85.97%	83.66%	80.75%	62.60%
Interest Burden Percent	102.98%	104.54%	103.71%	106.69%	113.74%	107.47%	102.13%	102.75%	111.62%	111.89%	110.22%
Effective Tax Rate	15.20%	11.18%	33.68%	6.53%	-25.08%	5.74%	12.24%	14.03%	16.34%	19.25%	37.40%
Return on Invested Capital (ROIC)	54.82%	64.92%	70.77%	68.29%	42.06%	31.99%	54.36%	38.25%	14.46%	10.00%	11.43%
ROIC Less NNEP Spread (ROIC-NNEP)	40.65%	63.91%	70.13%	66.75%	38.96%	30.07%	53.96%	37.81%	13.91%	7.72%	9.37%
Return on Net Nonoperating Assets (RNNOA)	-30.87%	-48.85%	-53.60%	-48.64%	-25.70%	-18.53%	-33.57%	-23.22%	-6.76%	-2.97%	-3.83%
Return on Equity (ROE)	23.95%	16.07%	17.17%	19.66%	16.37%	13.46%	20.79%	15.03%	7.69%	7.03%	7.61%
Cash Return on Invested Capital (CROIC)	37.63%	58.61%	50.05%	45.18%	1.34%	35.09%	48.86%	27.15%	-31.07%	9.82%	20.53%
Operating Return on Assets (OROA)	14.42%	16.10%	22.09%	17.06%	9.03%	9.44%	16.41%	12.32%	6.10%	5.86%	8.27%
Return on Assets (ROA)	21.89%	14.92%	15.19%	17.01%	12.84%	9.56%	14.71%	10.88%	5.70%	5.29%	5.71%
Return on Common Equity (ROCE)	23.95%	16.07%	17.17%	19.66%	16.37%	13.46%	20.79%	15.03%	7.69%	7.03%	7.61%
Return on Equity Simple (ROE_SIMPLE)	22.66%	14.93%	16.13%	19.31%	15.04%	13.96%	19.57%	14.98%	7.53%	7.00%	0.00%
Net Operating Profit after Tax (NOPAT)	103	137	172	207	178	161	277	212	109	93	102
NOPAT Margin	22.87%	25.84%	22.41%	25.64%	24.58%	19.82%	26.67%	21.04%	13.06%	10.16%	10.24%
Net Nonoperating Expense Percent (NNEP)	14.17%	1.00%	0.64%	1.54%	3.10%	1.91%	0.40%	0.44%	0.54%	2.28%	2.06%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	14.72%	7.27%	6.12%	6.82%
Cost of Revenue to Revenue	22.77%	24.75%	24.45%	25.55%	26.15%	25.45%	26.74%	28.25%	28.21%	31.57%	33.08%
SG&A Expenses to Revenue	34.77%	31.37%	28.81%	32.58%	37.74%	32.99%	29.83%	31.02%	40.49%	40.56%	36.59%
R&D to Revenue	15.49%	14.78%	12.95%	14.44%	16.46%	16.15%	13.05%	14.03%	16.64%	15.29%	13.98%
Operating Expenses to Revenue	50.26%	46.15%	41.76%	47.02%	54.20%	53.52%	42.88%	47.28%	56.18%	55.85%	50.57%
Earnings before Interest and Taxes (EBIT)	123	155	257	220	143	174	312	244	121	118	166
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	138	170	274	242	168	202	337	269	145	151	196
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.24	5.32	9.12	5.55	6.72	10.89	9.45	5.59	4.74	4.05	4.04
Price to Tangible Book Value (P/TBV)	3.63	5.96	10.31	6.23	8.49	13.71	11.49	6.79	7.14	5.90	5.89
Price to Revenue (P/Rev)	5.94	9.68	13.04	7.82	12.55	16.95	13.03	7.99	8.52	6.73	6.06
Price to Earnings (P/E)	14.31	35.66	56.53	28.76	44.67	78.01	48.30	37.28	62.99	57.93	52.69
Dividend Yield	0.67%	0.49%	0.00%	0.51%	0.38%	2.83%	2.94%	0.57%	0.69%	0.85%	0.90%
Earnings Yield	6.99%	2.80%	1.77%	3.48%	2.24%	1.28%	2.07%	2.68%	1.59%	1.73%	1.90%
Enterprise Value to Invested Capital (EV/IC)	10.07	20.14	34.23	16.31	16.19	26.23	24.12	12.29	7.06	5.98	6.34
Enterprise Value to Revenue (EV/Rev)	4.56	8.27	11.96	6.83	11.39	16.00	12.16	7.14	7.83	6.08	5.42
Enterprise Value to EBITDA (EV/EBITDA)	14.88	25.68	33.43	22.80	49.30	64.34	37.37	26.74	45.25	36.96	27.50
Enterprise Value to EBIT (EV/EBIT)	16.67	28.24	35.66	25.05	57.65	74.61	40.39	29.43	54.07	47.34	32.49
Enterprise Value to NOPAT (EV/NOPAT)	19.94	32.00	53.37	26.64	46.32	80.73	45.60	33.93	59.95	59.88	52.94
Enterprise Value to Operating Cash Flow (EV/OCF)	16.01	24.05	40.84	24.65	32.62	53.53	40.15	29.50	58.06	37.32	21.95
Enterprise Value to Free Cash Flow (EV/FCFF)	29.05	35.44	75.47	40.28	1,457.96	73.59	50.73	47.79	0.00	60.99	29.49
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.76	-0.76	-0.76	-0.73	-0.66	-0.62	-0.62	-0.61	-0.49	-0.39	-0.41
Leverage Ratio	1.09	1.08	1.13	1.16	1.27	1.41	1.41	1.38	1.35	1.33	1.33
Compound Leverage Factor	1.13	1.13	1.17	1.23	1.45	1.51	1.44	1.42	1.51	1.48	1.47
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	28.25	42.85	33.67	27.03	11.81	16.78	15.84	10.90	9.62	9.04	8.25
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	8.28	8.00	5.59	8.54	5.04	4.55	3.39	3.82	4.47	3.62	3.80
Quick Ratio	7.29	7.27	4.72	7.26	4.32	3.81	2.43	2.81	2.95	2.32	2.73
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	71	124	121	137	5.67	176	249	150	-235	91	183
Operating Cash Flow to CapEx	704.01%	1,420.73%	780.15%	602.38%	1,164.92%	1,822.15%	2,032.13%	1,237.64%	489.30%	991.03%	2,808.12%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.53	0.55	0.66	0.63	0.46	0.44	0.55	0.51	0.42	0.46	0.50
Accounts Receivable Turnover	10.87	10.54	8.30	6.34	6.16	6.77	7.81	7.68	6.86	6.96	6.41
Inventory Turnover	3.08	4.08	3.95	2.73	2.64	3.41	3.19	2.41	1.66	1.81	2.23
Fixed Asset Turnover	9.08	9.87	11.60	9.52	8.03	9.62	13.24	12.80	9.03	8.95	10.78
Accounts Payable Turnover	8.18	14.82	11.25	10.38	11.13	12.09	9.19	7.99	9.73	9.70	7.46
Days Sales Outstanding (DSO)	33.59	34.65	43.95	57.56	59.28	53.91	46.75	47.51	53.20	52.48	56.92
Days Inventory Outstanding (DIO)	118.42	89.56	92.48	133.92	138.06	107.06	114.48	151.29	219.93	202.15	163.89
Days Payable Outstanding (DPO)	44.63	24.63	32.44	35.16	32.79	30.18	39.70	45.69	37.50	37.61	48.96
Cash Conversion Cycle (CCC)	107.38	99.57	103.99	156.33	164.55	130.78	121.53	153.11	235.63	217.02	171.85
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	204	217	268	338	510	495	523	584	928	930	850
Invested Capital Turnover	2.40	2.51	3.16	2.66	1.71	1.61	2.04	1.82	1.11	0.98	1.12
Increase / (Decrease) in Invested Capital	32	13	50	70	173	-16	28	61	344	1.68	-81
Enterprise Value (EV)	2,055	4,378	9,162	5,507	8,262	12,977	12,610	7,182	6,556	5,564	5,388
Market Capitalization	2,677	5,124	9,990	6,305	9,107	13,744	13,518	8,036	7,132	6,151	6,030
Book Value per Share	$9.73	$11.24	$12.65	$6.59	$7.93	$7.23	$8.09	$8.32	$8.74	$8.85	$8.90
Tangible Book Value per Share	$8.70	$10.03	$11.19	$5.88	$6.28	$5.74	$6.65	$6.84	$5.80	$6.07	$6.11
Total Capital	826	963	1,096	1,135	1,356	1,262	1,430	1,438	1,505	1,518	1,492
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-622	-745	-828	-798	-845	-767	-907	-854	-576	-587	-642
Capital Expenditures (CapEx)	18	13	29	37	22	13	15	20	23	15	8.74
Debt-free, Cash-free Net Working Capital (DFCFNWC)	42	40	113	153	75	97	128	130	195	198	177
Debt-free Net Working Capital (DFNWC)	391	461	517	689	487	469	451	530	527	444	514
Net Working Capital (NWC)	391	461	517	689	487	469	451	530	527	444	514
Net Nonoperating Expense (NNE)	-84	-6.86	-5.04	-13	-26	-15	-3.33	-3.84	-3.89	-13	-13
Net Nonoperating Obligations (NNO)	-622	-745	-828	-798	-845	-767	-907	-854	-576	-587	-642
Total Depreciation and Amortization (D&A)	15	15	17	22	24	28	25	25	24	33	30
Debt-free, Cash-free Net Working Capital to Revenue	9.40%	7.50%	14.73%	19.03%	10.32%	11.97%	12.30%	12.91%	23.29%	21.64%	17.77%
Debt-free Net Working Capital to Revenue	86.74%	86.98%	67.53%	85.44%	67.08%	57.88%	43.51%	52.68%	62.94%	48.55%	51.66%
Net Working Capital to Revenue	86.74%	86.98%	67.53%	85.44%	67.08%	57.88%	43.51%	52.68%	62.94%	48.55%	51.66%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.09	$0.88	$1.02	$1.27	$1.19	$1.02	$1.59	$1.24	$0.66	$0.62	$0.68
Adjusted Weighted Average Basic Shares Outstanding	172.59M	170.68M	173.29M	172.33M	171.19M	173.49M	176.46M	173.41M	172.25M	171.44M	168.05M
Adjusted Diluted Earnings per Share	$1.07	$0.86	$0.99	$1.24	$1.16	$1.00	$1.56	$1.23	$0.65	$0.62	$0.68
Adjusted Weighted Average Diluted Shares Outstanding	175.98M	174.14M	179.55M	177.41M	175.27M	176.59M	179.92M	174.87M	173.40M	172.61M	169.37M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	169.77M	172.11M	173.55M	170.83M	172.61M	352.06M	347.83M	345.07M	343.27M	169.87M	165.71M
Normalized Net Operating Profit after Tax (NOPAT)	103	137	172	207	100	194	277	213	109	93	102
Normalized NOPAT Margin	22.87%	25.84%	22.41%	25.64%	13.76%	23.95%	26.67%	21.18%	13.06%	10.16%	10.24%
Pre Tax Income Margin	28.18%	30.61%	34.78%	29.09%	22.46%	23.05%	30.75%	24.92%	16.16%	14.38%	18.38%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	9.66%	17.55%	16.43%	14.53%	17.23%	221.65%	15.46%	21.31%	43.34%	49.29%	47.73%
Augmented Payout Ratio	77.20%	50.36%	86.44%	107.49%	47.49%	250.61%	73.22%	116.10%	113.81%	112.47%	180.22%

This table displays calculated financial ratios and metrics derived from Cognex's official financial filings.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	7/2/2023	10/1/2023	12/31/2023	3/31/2024	6/30/2024	9/29/2024	12/31/2024	3/30/2025	6/29/2025	9/28/2025	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-11.69%	-5.91%	-17.86%	4.81%	-1.33%	19.01%	16.79%	2.49%	4.10%	17.96%	9.86%
EBITDA Growth	0.11%	-37.85%	-67.99%	-19.15%	-32.54%	52.25%	95.53%	38.25%	11.24%	58.50%	17.88%
EBIT Growth	1.23%	-41.70%	-77.45%	-36.16%	-39.62%	49.22%	146.42%	64.81%	14.49%	77.81%	24.44%
NOPAT Growth	-7.21%	-37.91%	-80.38%	-55.11%	-39.38%	19.05%	145.22%	127.90%	9.28%	-36.47%	7.05%
Net Income Growth	-2.42%	-44.33%	-79.70%	-53.07%	-36.99%	56.43%	152.44%	96.33%	11.87%	-40.31%	15.23%
EPS Growth	-2.94%	-42.11%	-81.25%	-53.33%	-36.36%	54.55%	183.33%	100.00%	14.29%	-41.18%	17.65%
Operating Cash Flow Growth	-32.33%	-50.88%	-78.13%	-50.48%	-6.99%	37.17%	254.73%	196.87%	53.53%	55.47%	45.71%
Free Cash Flow Firm Growth	114.17%	-69.48%	-3,032.56%	-1,880.02%	-3,046.33%	-483.77%	106.80%	106.82%	112.80%	129.79%	379.47%
Invested Capital Growth	7.66%	12.49%	58.95%	54.80%	46.83%	49.29%	0.18%	0.03%	0.22%	-7.35%	-8.70%
Revenue Q/Q Growth	20.58%	-18.67%	-0.29%	7.18%	13.52%	-1.90%	-2.15%	-5.94%	15.30%	11.16%	-8.87%
EBITDA Q/Q Growth	144.61%	-60.38%	-26.49%	13.50%	104.11%	-10.60%	-5.60%	-19.75%	64.24%	27.39%	-29.79%
EBIT Q/Q Growth	181.43%	-65.28%	-41.96%	12.56%	166.18%	-14.19%	-4.15%	-24.72%	84.90%	33.27%	-32.92%
NOPAT Q/Q Growth	155.23%	-61.17%	-53.60%	-2.38%	244.63%	-23.73%	-4.43%	-9.27%	65.25%	-55.66%	61.05%
Net Income Q/Q Growth	124.38%	-67.09%	-40.64%	7.06%	201.21%	-18.28%	-4.21%	-16.73%	71.64%	-56.40%	84.92%
EPS Q/Q Growth	120.00%	-66.67%	-45.45%	16.67%	200.00%	-19.05%	0.00%	-17.65%	71.43%	-58.33%	100.00%
Operating Cash Flow Q/Q Growth	8.33%	37.44%	-64.68%	-5.85%	103.50%	102.68%	-8.65%	-21.21%	5.24%	105.24%	-14.38%
Free Cash Flow Firm Q/Q Growth	156.61%	-644.76%	-569.97%	4.17%	15.76%	-7.94%	107.80%	-3.88%	58.07%	151.27%	23.38%
Invested Capital Q/Q Growth	7.57%	-0.78%	44.41%	0.44%	2.02%	0.89%	-3.09%	0.29%	2.21%	-6.73%	-4.46%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	74.09%	72.39%	68.67%	67.33%	69.62%	67.90%	68.73%	66.81%	67.39%	67.64%	65.75%
EBITDA Margin	28.50%	13.88%	10.23%	10.84%	19.49%	17.76%	17.13%	14.62%	20.82%	23.86%	18.38%
Operating Margin	26.88%	15.53%	6.47%	6.74%	16.07%	13.45%	13.43%	12.08%	17.44%	20.86%	13.98%
EBIT Margin	26.26%	11.21%	6.53%	6.85%	16.07%	14.06%	13.77%	11.02%	17.67%	21.19%	15.60%
Profit (Net Income) Margin	23.70%	9.59%	5.71%	5.70%	15.13%	12.61%	12.34%	10.93%	16.26%	6.38%	12.94%
Tax Burden Percent	84.80%	70.05%	78.23%	68.44%	87.12%	80.95%	79.18%	84.91%	84.29%	28.10%	74.10%
Interest Burden Percent	106.43%	122.12%	111.84%	121.60%	108.10%	110.79%	113.20%	116.76%	109.18%	107.15%	112.00%
Effective Tax Rate	15.20%	29.95%	21.77%	31.56%	12.88%	19.05%	20.82%	15.09%	15.71%	71.90%	25.90%
Return on Invested Capital (ROIC)	32.55%	15.77%	5.61%	5.09%	14.78%	11.97%	10.46%	10.11%	14.34%	6.16%	11.57%
ROIC Less NNEP Spread (ROIC-NNEP)	32.28%	16.08%	5.43%	4.76%	14.38%	11.42%	9.79%	9.84%	13.64%	5.92%	10.51%
Return on Net Nonoperating Assets (RNNOA)	-18.22%	-9.29%	-2.64%	-2.27%	-6.68%	-5.43%	-3.77%	-3.59%	-5.02%	-2.34%	-4.29%
Return on Equity (ROE)	14.33%	6.48%	2.97%	2.82%	8.09%	6.54%	6.69%	6.53%	9.33%	3.82%	7.28%
Cash Return on Invested Capital (CROIC)	18.65%	13.01%	-31.07%	-30.44%	-28.58%	-29.75%	9.82%	11.28%	11.19%	18.42%	20.53%
Operating Return on Assets (OROA)	11.90%	5.07%	2.75%	2.91%	6.78%	6.11%	6.28%	5.14%	8.20%	10.13%	7.74%
Return on Assets (ROA)	10.74%	4.34%	2.41%	2.42%	6.38%	5.48%	5.63%	5.09%	7.54%	3.05%	6.42%
Return on Common Equity (ROCE)	14.33%	6.48%	2.97%	2.82%	8.09%	6.54%	6.69%	6.53%	9.33%	3.82%	7.28%
Return on Equity Simple (ROE_SIMPLE)	11.64%	10.57%	0.00%	6.69%	5.20%	5.68%	0.00%	8.15%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	55	21	9.96	9.72	34	26	24	22	37	16	26
NOPAT Margin	22.79%	10.88%	5.06%	4.61%	14.00%	10.88%	10.63%	10.26%	14.70%	5.86%	10.36%
Net Nonoperating Expense Percent (NNEP)	0.27%	-0.31%	0.18%	0.33%	0.39%	0.56%	0.68%	0.27%	0.70%	0.24%	1.06%
Return On Investment Capital (ROIC_SIMPLE)	-	-	0.66%	-	-	-	1.61%	1.53%	2.43%	1.09%	1.75%
Cost of Revenue to Revenue	25.91%	27.61%	31.33%	32.67%	30.38%	32.10%	31.27%	33.19%	32.61%	32.36%	34.25%
SG&A Expenses to Revenue	34.40%	41.73%	45.95%	42.99%	38.94%	39.46%	41.14%	38.65%	36.67%	34.11%	37.48%
R&D to Revenue	13.85%	16.52%	17.64%	17.60%	14.61%	15.00%	14.17%	16.07%	13.29%	12.67%	14.29%
Operating Expenses to Revenue	47.22%	56.85%	62.19%	60.60%	53.55%	54.46%	55.30%	54.73%	49.96%	46.78%	51.77%
Earnings before Interest and Taxes (EBIT)	64	22	13	14	38	33	32	24	44	59	39
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	69	27	20	23	47	42	39	32	52	66	46
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	6.47	4.88	4.74	4.89	5.32	4.41	4.05	3.53	3.51	5.16	4.04
Price to Tangible Book Value (P/TBV)	7.80	5.86	7.14	7.29	7.80	6.44	5.90	5.28	5.20	7.61	5.89
Price to Revenue (P/Rev)	10.73	8.24	8.52	8.59	9.49	7.83	6.73	5.54	5.68	7.91	6.06
Price to Earnings (P/E)	55.59	46.13	62.99	73.03	102.21	77.55	57.93	43.29	43.27	69.81	52.69
Dividend Yield	0.50%	0.66%	0.69%	0.69%	0.63%	0.75%	0.85%	1.03%	1.00%	0.70%	0.90%
Earnings Yield	1.80%	2.17%	1.59%	1.37%	0.98%	1.29%	1.73%	2.31%	2.31%	1.43%	1.90%
Enterprise Value to Invested Capital (EV/IC)	13.50	9.97	7.06	7.21	7.84	6.56	5.98	4.91	4.96	7.97	6.34
Enterprise Value to Revenue (EV/Rev)	9.80	7.28	7.83	7.93	8.83	7.15	6.08	4.98	5.09	7.29	5.42
Enterprise Value to EBITDA (EV/EBITDA)	42.83	34.17	45.25	48.18	63.74	47.98	36.96	28.79	28.75	37.53	27.50
Enterprise Value to EBIT (EV/EBIT)	48.31	38.78	54.07	59.43	84.88	63.80	47.34	36.14	35.70	44.82	32.49
Enterprise Value to NOPAT (EV/NOPAT)	53.80	42.63	59.95	69.61	99.55	80.28	59.88	43.47	43.52	71.03	52.94
Enterprise Value to Operating Cash Flow (EV/OCF)	42.24	38.93	58.06	67.87	76.93	56.16	37.32	26.06	24.78	31.92	21.95
Enterprise Value to Free Cash Flow (EV/FCFF)	75.08	81.13	0.00	0.00	0.00	0.00	60.99	43.59	44.37	41.61	29.49
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.56	-0.58	-0.49	-0.48	-0.46	-0.48	-0.39	-0.36	-0.37	-0.40	-0.41
Leverage Ratio	1.37	1.35	1.35	1.36	1.34	1.33	1.33	1.34	1.33	1.33	1.33
Compound Leverage Factor	1.46	1.65	1.51	1.65	1.45	1.47	1.50	1.57	1.45	1.43	1.49
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	12.36	9.95	9.45	9.41	10.82	9.48	8.89	7.34	7.47	10.16	8.04
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.98	4.99	4.47	3.52	4.03	3.94	3.62	3.14	3.29	3.96	3.80
Quick Ratio	2.88	3.80	2.95	2.23	2.67	2.62	2.32	1.98	2.18	2.79	2.73
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	9.16	-50	-334	-320	-270	-291	23	22	35	87	107
Operating Cash Flow to CapEx	635.09%	700.65%	206.57%	335.95%	615.59%	1,279.18%	2,479.69%	1,619.43%	1,942.80%	6,025.14%	2,885.29%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.45	0.45	0.42	0.43	0.42	0.44	0.46	0.47	0.46	0.48	0.50
Accounts Receivable Turnover	5.51	7.64	6.86	5.89	5.42	6.03	6.96	6.03	5.35	5.86	6.41
Inventory Turnover	2.23	2.02	1.66	1.66	1.82	1.93	1.81	1.81	1.99	2.10	2.23
Fixed Asset Turnover	11.08	10.84	9.03	9.14	9.14	9.47	8.95	9.19	9.46	10.07	10.78
Accounts Payable Turnover	10.65	10.80	9.73	9.11	10.58	10.50	9.70	8.24	9.25	8.33	7.46
Days Sales Outstanding (DSO)	66.19	47.80	53.20	62.00	67.31	60.50	52.48	60.57	68.18	62.28	56.92
Days Inventory Outstanding (DIO)	163.90	180.91	219.93	219.50	200.80	189.46	202.15	202.16	183.55	173.56	163.89
Days Payable Outstanding (DPO)	34.27	33.79	37.50	40.07	34.51	34.75	37.61	44.29	39.46	43.81	48.96
Cash Conversion Cycle (CCC)	195.82	194.92	235.63	241.43	233.59	215.21	217.02	218.43	212.28	192.03	171.85
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	648	643	928	933	951	960	930	933	954	889	850
Invested Capital Turnover	1.43	1.45	1.11	1.10	1.06	1.10	0.98	0.99	0.98	1.05	1.12
Increase / (Decrease) in Invested Capital	46	71	344	330	303	317	1.68	0.30	2.07	-71	-81
Enterprise Value (EV)	8,750	6,412	6,556	6,720	7,456	6,299	5,564	4,585	4,728	7,088	5,388
Market Capitalization	9,583	7,258	7,132	7,276	8,011	6,906	6,151	5,098	5,281	7,688	6,030
Book Value per Share	$8.58	$8.64	$8.74	$8.67	$8.78	$9.14	$8.85	$8.51	$8.97	$8.87	$8.90
Tangible Book Value per Share	$7.12	$7.18	$5.80	$5.81	$5.98	$6.26	$6.07	$5.68	$6.06	$6.02	$6.11
Total Capital	1,480	1,489	1,505	1,489	1,507	1,567	1,518	1,446	1,506	1,490	1,492
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-832	-846	-576	-557	-555	-607	-587	-513	-553	-600	-642
Capital Expenditures (CapEx)	4.70	5.86	7.02	4.06	4.51	4.40	2.07	2.50	2.19	1.45	2.60
Debt-free, Cash-free Net Working Capital (DFCFNWC)	169	165	195	195	223	213	198	193	207	201	177
Debt-free Net Working Capital (DFNWC)	538	677	527	473	512	501	444	394	435	502	514
Net Working Capital (NWC)	538	677	527	473	512	501	444	394	435	502	514
Net Nonoperating Expense (NNE)	-2.21	2.55	-1.27	-2.30	-2.71	-4.04	-3.93	-1.45	-3.90	-1.43	-6.52
Net Nonoperating Obligations (NNO)	-832	-846	-576	-557	-555	-607	-587	-513	-553	-600	-642
Total Depreciation and Amortization (D&A)	5.43	5.27	7.29	8.40	8.18	8.69	7.73	7.77	7.85	7.41	7.04
Debt-free, Cash-free Net Working Capital to Revenue	18.93%	18.70%	23.29%	23.04%	26.44%	24.22%	21.64%	21.01%	22.28%	20.72%	17.77%
Debt-free Net Working Capital to Revenue	60.26%	76.94%	62.94%	55.88%	60.69%	56.87%	48.55%	42.81%	46.83%	51.63%	51.66%
Net Working Capital to Revenue	60.26%	76.94%	62.94%	55.88%	60.69%	56.87%	48.55%	42.81%	46.83%	51.63%	51.66%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.33	$0.11	$0.07	$0.07	$0.21	$0.17	$0.17	$0.14	$0.24	$0.11	$0.19
Adjusted Weighted Average Basic Shares Outstanding	172.43M	172.17M	172.25M	171.69M	171.57M	171.52M	171.44M	169.27M	167.89M	167.84M	168.05M
Adjusted Diluted Earnings per Share	$0.33	$0.11	$0.06	$0.07	$0.21	$0.17	$0.17	$0.14	$0.24	$0.10	$0.20
Adjusted Weighted Average Diluted Shares Outstanding	173.62M	173.35M	173.40M	172.59M	172.73M	172.75M	172.61M	170.39M	168.56M	169.32M	169.37M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	172.29M	172.14M	343.27M	171.66M	171.50M	171.52M	169.87M	167.86M	167.90M	167.60M	165.71M
Normalized Net Operating Profit after Tax (NOPAT)	55	21	9.96	9.72	34	26	24	22	37	40	26
Normalized NOPAT Margin	22.79%	10.88%	5.06%	4.61%	14.00%	10.88%	10.63%	10.26%	14.70%	14.60%	10.36%
Pre Tax Income Margin	27.95%	13.69%	7.30%	8.33%	17.37%	15.57%	15.59%	12.87%	19.29%	22.70%	17.47%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	27.56%	30.70%	43.34%	50.06%	64.65%	57.82%	49.29%	45.00%	43.88%	49.16%	47.73%
Augmented Payout Ratio	85.08%	85.09%	113.81%	115.24%	129.10%	107.22%	112.47%	180.86%	166.32%	203.41%	180.22%

Financials Breakdown Chart

Key Financial Trends

Here is a concise, investor‑focused take on Cognex (CGNX) using the quarterly figures provided for the last four years. The highlights focus on revenue, margins, cash flow, and balance‑sheet health, with a quick read on liquidity and capital allocation.

Revenue has trended up across 2025, with Q4 2025 at $252.3 million (vs. $229.7 million in Q4 2024) and Q3 2025 at $276.9 million, signaling a multi‑quarter uptrend in top line.
Gross margin has remained strong and relatively stable in the mid‑60s to high‑60s percent range (about 66%–68% in 2025), indicating solid pricing power and cost control.
Operating cash flow was robust in 2025, with notable reads of about $87.5 million in Q3 and $74.9 million in Q4, improving versus the $51.4 million level in 2024 Q4.
The balance sheet remains solid, with Total Assets near $2.0 billion and Total Equity around $1.5 billion; cash on hand rose to roughly $246 million by Q3 2025, and leverage remains minimal.
Earnings per share show improvement in 2025, with Q4 2025 Basic EPS of $0.19 and Diluted EPS of $0.20, and Q2 2025 EPS at $0.24, reflecting a favorable trend in profitability.
Free cash flow was positive in Q4 2025 (approx. $74.9 million operating cash flow minus around $2.6 million for capex), underscoring strong cash‑generation efficiency.
Dividend per share remains at $0.08, indicating a steady, shareholder‑friendly payout policy without a dramatic increase or cut.
G&A and R&D spend stayed relatively steady (SG&A around $90–95 million; R&D around $34–37 million in 2025), suggesting disciplined cost management without dramatic swings.
Financing activities show negative cash flow in multiple 2025 quarters due to stock buybacks and dividends, which press on near‑term liquidity despite strong operating cash flow.

05/06/26 11:53 PM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Cognex's Financials

When does Cognex's financial year end?

According to the most recent income statement we have on file, Cognex's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

How has Cognex's net income changed over the last 10 years?

Cognex's net income appears to be on a downward trend, with a most recent value of $114.44 million in 2025, falling from $187.07 million in 2015. The previous period was $106.17 million in 2024. Check out Cognex's forecast to explore projected trends and price targets.

What is Cognex's operating income?

Cognex's total operating income in 2025 was $162.57 million, based on the following breakdown:

Total Gross Profit: $665.39 million
Total Operating Expenses: $502.83 million

How has Cognex's revenue changed over the last 10 years?

Over the last 10 years, Cognex's total revenue changed from $450.56 million in 2015 to $994.36 million in 2025, a change of 120.7%.

How much debt does Cognex have?

Cognex's total liabilities were at $524.65 million at the end of 2025, a 10.4% increase from 2024, and a 745.0% increase since 2015.

How much cash does Cognex have?

In the past 10 years, Cognex's cash and equivalents has ranged from $51.98 million in 2015 to $269.07 million in 2020, and is currently $262.93 million as of their latest financial filing in 2025.

How has Cognex's book value per share changed over the last 10 years?

Over the last 10 years, Cognex's book value per share changed from 9.73 in 2015 to 8.90 in 2025, a change of -8.5%.

Related Companies

Financial statements for NASDAQ:CGNX last updated on 2/12/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cognex (CGNX) Financials

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Cognex's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cognex (CGNX) Financials

Annual Income Statements for Cognex

Quarterly Income Statements for Cognex

Annual Cash Flow Statements for Cognex

Quarterly Cash Flow Statements for Cognex

Annual Balance Sheets for Cognex

Quarterly Balance Sheets for Cognex

Annual Metrics And Ratios for Cognex

Quarterly Metrics And Ratios for Cognex

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Cognex's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools